181 related articles for article (PubMed ID: 26883907)
1. Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs.
Kim H; Kim Y; Goh H; Jeoung D
Mol Cells; 2016 Mar; 39(3):229-41. PubMed ID: 26883907
[TBL] [Abstract][Full Text] [Related]
2. miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.
Kim Y; Kim H; Park D; Han M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
Oncotarget; 2016 Mar; 7(9):10297-321. PubMed ID: 26863629
[TBL] [Abstract][Full Text] [Related]
3. miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.
Kim Y; Kim H; Park H; Park D; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2014 Oct; 289(40):28019-39. PubMed ID: 25138213
[TBL] [Abstract][Full Text] [Related]
4. miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.
Kim Y; Park D; Kim H; Choi M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2013 Dec; 288(51):36502-18. PubMed ID: 24174534
[TBL] [Abstract][Full Text] [Related]
5. Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance.
Kwon Y; Kim Y; Jung HS; Jeoung D
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583572
[TBL] [Abstract][Full Text] [Related]
6. miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs.
Park D; Kim H; Kim Y; Jeoung D
Mol Cells; 2016 Apr; 39(4):299-309. PubMed ID: 26912082
[TBL] [Abstract][Full Text] [Related]
7. Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.
Kim Y; Park H; Park D; Lee YS; Choe J; Hahn JH; Lee H; Kim YM; Jeoung D
J Biol Chem; 2010 Aug; 285(34):25957-68. PubMed ID: 20534591
[TBL] [Abstract][Full Text] [Related]
8. miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3.
Kim Y; Kim H; Park D; Jeoung D
Mol Cells; 2015 Jun; 38(6):562-72. PubMed ID: 25997740
[TBL] [Abstract][Full Text] [Related]
9. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
10. Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.
Kim Y; Kim H; Jeoung D
Mol Cells; 2015 Aug; 38(8):705-14. PubMed ID: 26126538
[TBL] [Abstract][Full Text] [Related]
11. DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2.
Kim Y; Yeon M; Jeoung D
Mol Cells; 2017 May; 40(5):322-330. PubMed ID: 28535666
[TBL] [Abstract][Full Text] [Related]
12. Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.
Yu S; Gong X; Ma Z; Zhang M; Huang L; Zhang J; Zhao S; Zhu T; Yu Z; Chen L
Cell Oncol (Dordr); 2020 Feb; 43(1):65-80. PubMed ID: 31701491
[TBL] [Abstract][Full Text] [Related]
13. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis.
Dong L; Huang J; Zu P; Liu J; Gao X; Du J; Li Y
Bioengineered; 2021 Dec; 12(1):7995-8005. PubMed ID: 34658308
[TBL] [Abstract][Full Text] [Related]
15. The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.
Kim Y; Kim H; Park D; Lee H; Lee YS; Choe J; Kim YM; Jeon D; Jeoung D
Oncotarget; 2017 Feb; 8(8):13632-13651. PubMed ID: 28099142
[TBL] [Abstract][Full Text] [Related]
16. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase-3 mediates positive feedback relationship between anaphylaxis and tumor metastasis.
Eom S; Kim Y; Park D; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2014 Apr; 289(17):12126-12144. PubMed ID: 24619412
[TBL] [Abstract][Full Text] [Related]
18. HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p.
Chen Z; Pei L; Zhang D; Xu F; Zhou E; Chen X
Int J Biochem Cell Biol; 2021 Jun; 135():105967. PubMed ID: 33727043
[TBL] [Abstract][Full Text] [Related]
19. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.
Kong L; Deng Z; Shen H; Zhang Y
Mol Cell Biochem; 2011 Feb; 348(1-2):11-9. PubMed ID: 21052789
[TBL] [Abstract][Full Text] [Related]
20. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer.
Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M
Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
